Navigation Links
Regulus to Present at the Lazard Capital Markets Healthcare Conference
Date:11/8/2012

LA JOLLA, Calif., Nov. 8, 2012 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Kleanthis G. Xanthopoulos, Ph.D., President and CEO of Regulus, will present a company overview at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14, 2012 at 1:00 PM EST at the Pierre Hotel in New York City. 

The presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com.  A replay of the webcast will be archived on the Company's website for two weeks following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals (NASDAQ: ALNY) and Isis Pharmaceuticals (NASDAQ: ISIS). Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://www.regulusrx.com.

Forward-Loo
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
2. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
3. Regulus Files Registration Statement for Proposed Initial Public Offering
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
9. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
10. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
11. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Donald Fresne, President and CEO of Egenix, Inc. is pleased ... to its Scientific Advisory Committee. Dr. Vagner, a ... , performed research at Embl (European Molecular Biology Laboratory) Heidelberg, ... institute of health and medical research. He is a Research ... Orsay, France , and at the Gustave ...
(Date:9/16/2014)... Norris, TN (PRWEB) September 16, 2014 ... several new initiatives to position themselves for ... capabilities for labeling and encoding, Pharma Packaging ... adding new hardware and software and new ... on current Good Manufacturing Practices (cGMP), Pharma ...
(Date:9/16/2014)... Denmark , Sept. 16, 2014  Ascendis ... innovative TransCon technology to address significant unmet medical ... ongoing Phase 2 pediatric study to evaluate once-weekly ... deficiency, or GHD.  The full interim results will ... the GRS and IGF Society, being held October ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 RENU 28, the ... molecules, became available for purchase in Australia and New ... nationwide tour beginning September 16th. The tour will make stops ... 17th, Bundaberg on the 18th, Sydney on the 20th, and ... in Australia and New Zealand and to educate people about ...
Breaking Biology Technology:New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Global Wellness Company Hosts ASEA Australia Tour September 16-22 2
... , WALTHAM, Mass. , Jan. 29 ... President and Chief Executive Officer, Walter C. Herlihy , Ph.D., ... 4th, 2010 at 10:00 a.m. EST , to report ... quarterly update of the Company. , This call is being webcast ...
... SANTA CLARA, Calif. , Jan. 28 Coherent, Inc. (Nasdaq: COHR ), a world leader in providing photonics based solutions to ... , , , , , ... Three Months Ended, ... ------------------, GAAP Results ...
... , , ... group,AstraZeneca announced it,s Q4 and full-year results today with CEO ... that cost,control and restructuring had helped deliver a revenue line above ... looks at the results and the drivers behind a 23%,rise in ...
Cached Biology Technology:Repligen Announces Conference Call of Third Quarter Fiscal Year 2010 Results Thursday, February 4th, 10:00 a.m. EST 2Repligen Announces Conference Call of Third Quarter Fiscal Year 2010 Results Thursday, February 4th, 10:00 a.m. EST 3Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 2Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 3Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 4Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 5Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 6Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 7Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 8Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 9Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 10Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 11Coherent, Inc. Reports Strong First Fiscal Quarter Results and Raises Annual Sales Guidance 12AstraZeneca CEO Interviewed on Q4 and Full-Year Results 2009 2
(Date:9/16/2014)... From the salmon-rich waters of Southeast Alaska to ... Downeast Maine,s lobster, lumber and tourist towns, coastal residents ... about coastal environments divide along political lines. That,s a ... New Hampshire sociologists published this month in the journal ... a lot of environment-related differences from place to place ...
(Date:9/16/2014)... What motivates consumers to make ethical choices such as ... more money on fair-trade coffee, and bringing their own ... study in the Journal of Consumer Research , ... to turn their emotions about unethical practices into action. ... consider the environmental and human costs of the products ...
(Date:9/16/2014)... practically all vital functions in an organism. For ... particular substances and control immune system responses. Researchers ... function independently of each other, but instead form ... networks, you find many similarities with online social ... of Plant Systems Biology. "Some proteins are good ...
Breaking Biology News(10 mins):Politics divide coastal residents' views of environment, UNH research finds 2Politics divide coastal residents' views of environment, UNH research finds 3Why are consumers willing to spend more money on ethical products? 2Good networkers make prime targets 2
... Microbiology (ASM) Roche Diagnostics Alice C. Evans Award will ... Director, Walter Reed Army Institute of Research, Silver ... This award recognizes contributions toward the full participation and ... honor of Alice C. Evans, the first woman elected ...
... does more damage than just leaving you with puffy eyes. ... more dangerous, researchers say, than those pesky love handles and ... Wake Forest University School of Medicine reveals how extremes of ... be hazardous to your health especially for young minority ...
... own skin cells soon could be used to repair damaged ... University of Houston,s newest biomedical scientist, Robert Schwartz. ... him at the forefront of a revolution in medicine that ... dystrophy and many other diseases. Schwartz brings ...
Cached Biology News:Extremes of sleep related to increased fat around organs 2Extremes of sleep related to increased fat around organs 3Using own skin cells to repair hearts on horizon 2Using own skin cells to repair hearts on horizon 3
Sheep polyclonal to Quinolone ( Abpromise for all tested applications). Antigen: Norfloxacin(N)conjugated to BSA...
DONOR BOVINE SERUM AND PLASMA...
The Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 6 microcentrifuge tubes....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: